Abstract
Malignant lymphoma usually arises from the haematopoietic cells of B- or T-cell origin, and only rarely from the reticular supporting cells of the bone marrow and lymph nodes. It is one of the rapidly increasing malignancies with a more than 50% increase in incidence over the past 15 years. This is due to several predisposing factors such as the acquired immunodeficiency syndrome, either due to HIV infection or following the use of immunosuppressive drugs for organ transplantation; other predisposing factors include pesticides, previous radiation exposure and viral infection. The course of the disease differs significantly in adults and children.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Castellino, R.A. (1990) Diagnostic imaging of abdominal and pelvic lymph nodes in lymphoma. Radiol Clin. North Am., 28, 801–31.
Mauch, P., Larson, D., Osteen, R. et al. (1990) Prognostic factors for positive surgical staging in patients with Hodgkin’s disease.J. Clin. Oncol., 8, 257–65.
Nyman, R., Rehn, S., Glimelius, B. et al. (1988) Magnetic resonance imaging, chest radiography, computed tomography, and ultrasonography in malignant lymphoma. Acta Radiol, 28, 253–62.
Cohen, M.D., Klatte, E.C., Smith, J.A. et al. (1985) Magnetic resonance imaging of lymphomas in children. Pediatr. Radiol., 15, 179–83.
Zimmerman, R.A. (1990) Central nervous system lymphoma. Radiol. Clin. North Am., 28, 697–721.
Shields, A.F., Porter, B.A., Churchley, S. et al. (1987) The detection of bone marrow involvement by lymphoma using magnetic resonance imaging.J. Clin. Oncol., 4, 225–30.
Strauss, S., Lisbon, E., Schwartz, E. et al. (1986) Renal sonography in American Burkitt lymphoma. Am. J. Roentgenol., 146, 549–52.
Sener, R.N., Alper, H., Demirci, A. and Diren, H.B. (1989) A different sonographic ‘pseudokidney’ appearance detected with intestinal lymphoma: ‘Hydronephrotic pseudokidney’.J. Clin. Ultrasound, 17, 209–12.
Tumeh, S.S., Rosenthal, D.S., Kaplan, W.D., English, R.J. and Holman, B.L. (1987) Lymphoma: evaluation with Ga-67 SPECT. Radiology, 164(1), 114–14.
Rossleigh, M.A., Murray, P.L., Mackey, D.W., Bargwanna, K.A. and Nayanar, V.V. (1990) Pediatric solid tumors: evaluation of Ga-67 SPECT studies.J. Nucl. Med., 31, 168–72.
Israel, O., Front, D., Epelbaum, R. et al. (1990) Residual mass and negative Ga-67 scintigraphy in treated lymphoma.J. Nucl. Med., 31, 365–8.
Front, D., Benen-dashhaim, S., Israel, O. et al. (1992) Lymphoma: predictive value of Ga-67 scintigraphy after treatment. Radiology, 182, 359–63.
Drossman, S.R., Schiff, R.G., Kronfeld, G.D., McNamara, J. and Leonidas, J.C. (1990) Lymphoma of the mediastinum and neck: evaluation with Ga-67 imaging and CT correlation. Radiology, 174, 171–5.
Turner, D.A., Fordham, E.W. and Ali, A. (1978) Gallium-67 imaging in the management of Hodgkin’s disease and other malignant lymphomas. Semin. Nucl. Med., 8, 205–14.
Weiner, M., Leventhal, B., Cantor, A. et al. (1991) Gallium-67 scans as an adjunct to computed tomography scans for the assessment of a residual mediastinal mass in pediatric patients with Hodgkin’s disease. Cancer, 68(11), 2478–80.
Neuman, R.D., Kemp, J.D. and Weiner, R.E. (1996) Gallium-67 imaging for detection of malignant disease, in Diagnostic Nuclear Medicine (ed. M.P. Sandler, R.E. Coleman, F.J.Th. Wackers et al), 3rd edn, Williams & Wilkins, pp. 1243–60.
Front, D. and Israel, O. (1995) The role of gallium scintigraphy in evaluating the results of therapy in lymphoma patients. Semin. Nucl. Med., 25(1), 60–71.
Abdel-Dayem, H.M., Scott, A., Macapinlac, H.A., Elgazzar, A. and Larson, S.M. (1994) Role of Tl-201 chloride and Tc-99m sestaMIBI in tumour imaging. Nucl. Med. Annual, 181–234.
Waxman, A.D., Eller, D., Ashook, G. et al. (1996) Comparison of gallium-67 citrate and thallium-201 scintigraphy in peripheral and intrathoracic lymphoma.J. Nucl. Med., 37(1), 46–50.
Newman, J.S., Francis, I.R., Kaminski, M.S. and Wahl, R.L (1994) Imaging of lymphoma with PET with 2[F-18]-fluoro-2-deoxy-D-glucose: correlation with CT. Radiology, 190, 111–16.
Okada, J., Yoshikawa, K., Itami, M. et al. (1992) Positron emission tomography using fluorine-18-fluorodeoxyglucose in malignant lymphoma: a comparison with proliferative activity.J. Nucl. Med., 33, 325–9.
Okada, J., Yoshikawa, K., Itami, M. et al. (1987) The use of FDG-PET in the detection and management of malignant lymphoma: correlation of uptake with prognosis.J. Nucl. Med., 28, 288–92.
Paul, R. (1987) Comparison of fluorine-18–2-fluorodeoxyglucose and Ga-67 citrate imaging for detection of lymphoma.J. Nucl. Med., 28, 288–92.
Rodriguez, M., Rehn, S., Ahlstrom, S., Sundstrom, C. and Glimelius, B. (1995) Predicting malignancy grade with PET in Non-Hodgkin’s Lymphoma. J. Nucl. Med., 36, 1790–6.
Hiruma, K., Koike, T., Nakamura, H., Sumida, T., Maeda, T., Tomioka, H., Yoshida, S. and Fujita, T. (1990) Somatostatin receptors on human lymphocytes and leukaemia cells. Immunology, 71, 480–5.
Sarda, L., Duet, M., Zini, J.M., Berolatti, B., Benelhadj, S., Tobelem, G. and Mundler, O. (1995) In-111 Pentetreotide scintigraphy in malignant lymphomas. Eur.J. Nucl. Med., 22, 1105–9.
Goldsmith, S.J., Macapinlac, H.M. and O’Brien, J. (1995) Somatostatin receptor imaging in lymphoma. Semin. Nucl. Med., 25(3), 262–71.
Macapinlac, H.A., Scott, A.M., Larson, S.M., Divgi, C.R., Yeh, D.J. and Goldsmith, S.J. (1994) Gallium-67 citrate imaging in nuclear oncology. Nucl. Med. Biol., 21(5), 731–8.
Scott, A.M., Macapinlac, H.A., Zhang, J.J., Kalagian, H., Graham, M.C., Divgi, C.R., Goldsmith, S.J. and Larson, S.M. (2994) Clinical applications of fusion imaging in oncology. Nucl. Med. Biol., 21(5), 775–84.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Abdel-Dayem, H.M., Macapinlac, H.A. (1998). Lymphomas. In: Maisey, M.N., Britton, K.E., Collier, B.D. (eds) Clinical Nuclear Medicine. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-3356-0_39
Download citation
DOI: https://doi.org/10.1007/978-1-4899-3356-0_39
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-412-75180-6
Online ISBN: 978-1-4899-3356-0
eBook Packages: Springer Book Archive